Skip to main content
SpringerLink
Log in

Epidemiology of Osteoporosis

Implications for Drug Therapy

  • Review Article
  • Epidemiology
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Osteoporosis represents a major health problem. Fractures secondary to decreased bone mass and disrupted bone structure vastly increase morbidity in postmenopausal women, and morbidity as well as mortality in elderly people of either sex. Prophylaxis is possible, and indeed appears to be vital to ensure a high peak bone mass. Peak bone mass is reached during the second or third decade of life, i.e. 20 to 50 years before the appearance of osteoporotic fractures. Exercise and a sufficient calcium intake are possible measures in the early years. During menopause, estrogen replacement therapy will delay the accelerated bone loss and, most likely, also osteoporotic fractures. In established osteoporosis, a number of well documented therapies are now available. Depending on the age of the patient, bisphosphonates, calcitriol or other vitamin D preparations, calcium and calcitonin may be employed. This article reviews the epidemiology of osteoporotic fractures with special reference to the therapeutic implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodelling. N Engl J Med 1995; 332: 305–11

    Article  PubMed  CAS  Google Scholar 

  2. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284–7

    Article  PubMed  CAS  Google Scholar 

  3. Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. N Engl J Med 1992; 327: 620–7

    Article  PubMed  CAS  Google Scholar 

  4. Report of the Advisory Group on Osteoporosis. London: Department of Health, 1994 Nov

  5. Cummings SR, Kelsey JL, Nevitt MC, et al. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178–208

    PubMed  CAS  Google Scholar 

  6. Jacobsen SJ, Goldberg J, Miles TP, et al. Regional variation in the incidence of hip fracture. JAMA 1990; 264: 500–2

    Article  PubMed  CAS  Google Scholar 

  7. Johnell O, Gullberg B, Allander E, et al. The apparent incidence of hip fracture in Europe: a study of national register sources. MEDOS Study Group. Osteoporos Int 1992; 2: 298–302

    Article  PubMed  CAS  Google Scholar 

  8. Lewis F. Fracture of neck of the femur: changing incidence. BMJ 1981; 283: 1217–20

    Article  PubMed  CAS  Google Scholar 

  9. Wallace WA. The increasing incidence of fractures of the proximal femur: an orthopaedic epidemic. Lancet 1983; 1: 1413–4

    Article  PubMed  CAS  Google Scholar 

  10. Elabdien BSZ, Olerud S, Karlstrom G, et al. Rising incidence of hip fracture in Uppsala, 1965–1980. Acta Orthop Scand 1984; 55: 284–9

    Article  Google Scholar 

  11. Zetterberg C, Elmerson S, Andersson G. Epidemiology of hip fractures in Goteborg, Sweden, 1940–1983. Clin Orthop Relat Res 1984; 191: 43–52

    PubMed  Google Scholar 

  12. Falch JA, Kaastad TS, Bohler G, et al. Secular increase and geographical differences in hip fracture incidence in Norway. Bone 1993; 14: 643–5

    Article  PubMed  CAS  Google Scholar 

  13. Lauritzen JB, Schwarz P, Lund B, et al. Changing incidence and residual lifetime risk of common osteoporosis-related fractures. Osteoporos Int 1993; 3: 127–32

    Article  PubMed  CAS  Google Scholar 

  14. Melton LJ, Ilstrup DM, Riggs BL, et al. Fifty-year trend in hip fracture incidence. Clin Orthop Relat Res 1982; 162: 144–9

    PubMed  Google Scholar 

  15. Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992; 2: 285–9

    Article  PubMed  CAS  Google Scholar 

  16. Cooper C, Atkinson EJ, Jacobsen SJ, et al. Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993; 137: 1001–5

    PubMed  CAS  Google Scholar 

  17. Cummings SR, Black DM, Rubin SM. Lifetime risks of hip, Colles’, or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 1989; 149: 2445–8

    Article  PubMed  CAS  Google Scholar 

  18. Eiskjaer S, Ostgard SE, Jakobsen BW, et al. Years of potential life lost after hip fracture among postmenopausal women. Acta Orthop Scand 1992; 63: 293–6

    Article  PubMed  CAS  Google Scholar 

  19. Chrischilles EA, Butler CD, Davis CS, et al. A model of lifetime osteoporosis impact. Arch Intern Med 1991; 151: 2026–32

    Article  PubMed  CAS  Google Scholar 

  20. Jensen GF, Christiansen C, Boesen J, et al. Epidemiology of postmenopausal spinal and long bone fractures. Clin Orthop Relat Res 1982; 166: 75–81

    PubMed  Google Scholar 

  21. Melton LJ, Lane AW, Cooper C, et al. Prevalence and incidence of vertebral deformities. Osteoporos Int 1993; 3: 113–9

    Article  PubMed  Google Scholar 

  22. Spector TD, McCloskey EV, Doyle DV, et al. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford study. J Bone Miner Res 1993; 8: 817–22

    Article  PubMed  CAS  Google Scholar 

  23. Cooper C, O’Neill T, Silman A. The epidemiology of vertebral fractures. Bone 1993; 14: S87–S89

    Google Scholar 

  24. Cooper C, Atkinson EJ, Kotowicz M, et al. Secular trends in the incidence of postmenopausal vertebral fractures. Calcif Tissue Int 1992; 51: 100–4

    Article  PubMed  CAS  Google Scholar 

  25. Hansen MA, Overgaard K, Nielsen VA, et al. No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis. Osteoporos Int 1992; 2: 241–6

    Article  PubMed  CAS  Google Scholar 

  26. Cooper C, Atkinson EJ, O’Fallon WM, et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 1992; 7: 221–7

    Article  PubMed  CAS  Google Scholar 

  27. Kanis JA, Mccloskey EV. Epidemiology of vertebral osteoporosis. Bone 1992; 13 Suppl. 2: S1–10

    PubMed  Google Scholar 

  28. Ross PD, Davis JW, Epstein RS, et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114: 919–23

    PubMed  CAS  Google Scholar 

  29. Gardsell P, Johnell O, Nilsson BE, et al. The predictive value of fracture, disease, and falling tendency for fragility fractures in women. Calcif Tissue Int 1989; 45: 327–30

    Article  PubMed  CAS  Google Scholar 

  30. Kotowicz MA, Melton LJ, Cooper C, et al. Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 1994; 9: 599–605

    Article  PubMed  CAS  Google Scholar 

  31. Cooper C, Shah S, Hand DJ, et al. Screening for vertebral osteoporosis using individual risk factors. Osteoporos Int 1991; 2: 48–53

    Article  PubMed  CAS  Google Scholar 

  32. Hemert AM, Vandenbroucke JP, Birkenhäger JC, et al. Prediction of osteoporotic fractures in the general population by a fracture risk score. Am J Epidemiol 1990; 132: 123–35

    PubMed  Google Scholar 

  33. Melton LJ, Atkinson EJ, O’Fallon WM, et al. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993; 8: 1227–33

    Article  PubMed  Google Scholar 

  34. Gardsell P, Johnell O, Nilsson BE, et al. Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study. Calcif Tissue Int 1993; 52: 348–53

    Article  PubMed  CAS  Google Scholar 

  35. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993; 341: 72–5

    Article  PubMed  CAS  Google Scholar 

  36. Mallmin H, Ljunghall S, Persson I, et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int 1993; 52: 269–72

    Article  PubMed  CAS  Google Scholar 

  37. Wasnich RD, Davis JW, Ross PD. Spine fracture risk is predicted by non-spine fractures. Osteoporos Int 1994; 4: 1–5

    Article  PubMed  CAS  Google Scholar 

  38. Mosekilde L, Hermann AP, Beck-Nielsen H, et al. The Danish Osteoporosis Prevention Study: project design and inclusion of 2015 perimenopausal women. J Bone Miner Res 1994; 9: S265

    Google Scholar 

  39. Black DM, Cummings SR, Melton LJ. Appendicular bone mineral and a woman’s lifetime risk of hip fracture. J Bone Miner Res 1992; 7: 639–46

    Article  PubMed  CAS  Google Scholar 

  40. Lindsay R. Prevention and treatment of osteoporosis. Lancet 1993; 341: 801–5

    Article  PubMed  CAS  Google Scholar 

  41. Hopper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med 1994; 330: 387–92

    Article  PubMed  CAS  Google Scholar 

  42. Paganini Hill A, Chao A, Ross RK, et al. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology 1991; 2: 16–25

    Article  Google Scholar 

  43. Forsen L, Bjørndal A, Bjartveit K, et al. Interaction between current smoking, leanness, and physical inactivity in the prediction of hip fractures. J Bone Miner Res 1994; 9: 1671–86

    Article  PubMed  CAS  Google Scholar 

  44. Talmage RV, Stinnett SS, Landwehr JT, et al. Age-related loss of bone mineral density in non-athletic and athletic women. Bone Miner 1986; 1: 115–25

    PubMed  CAS  Google Scholar 

  45. Pocock N, Eisman J, Gwinn T, et al. Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass. J Bone Miner Res 1989; 4: 441–8

    Article  PubMed  CAS  Google Scholar 

  46. Bevier WC, Wiswell RA, Pyka G, et al. Relationship of body composition, muscle strength, and aerobic capacity to bone mineral density in older men and women. J Bone Miner Res 1989; 4: 421–32

    Article  PubMed  CAS  Google Scholar 

  47. Sinaki M, McPhee MC, Hodgson SF, et al. Relationship between bone mineral density of spine and strength of back extensors in healthy postmenopausal women. Mayo Clin Proc 1986; 61: 116–22

    PubMed  CAS  Google Scholar 

  48. Krølner B, Toft B, Nielsen SP, et al. Physical exercise as prophylaxis against involutional vertebral bone loss: a controlled trial. Clin Sci 1983; 64: 541–6

    PubMed  Google Scholar 

  49. Chow R, Harrison JE, Notarius C. Effect of two randomized exercise programmes on bone mass of healthy postmenopausal women. BMJ 1987; 295: 1441–4

    Article  PubMed  CAS  Google Scholar 

  50. Vetter JV, Lewis PA, Ford D. Can health visitors prevent fractures in elderly people? BMJ 1992; 304: 888–90

    Article  PubMed  CAS  Google Scholar 

  51. Poulstrup A. Prevention of injury related to falling accidents in free living elderly people [in Danish]. Vejle: Samfunds-medicinsk Forlag, 1992

    Google Scholar 

  52. Heaney RP. Calcium and osteoporosis, Bethesda: Federation of American Societies for Experimental Biology, 1991; Committee on Medical aspects of Food Policy. Dietary reference values for food energy and nutrients for the United Kingdom. London: Department of Health, 1991: 135–45

    Google Scholar 

  53. Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993; 328: 460–4

    Article  PubMed  CAS  Google Scholar 

  54. Dawson Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323: 878–83

    Article  PubMed  CAS  Google Scholar 

  55. Cumming RG. Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Intern 1990; 47: 194–201

    Article  CAS  Google Scholar 

  56. Johnston CC, Miller JZ, Slemenda CW, et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992; 327: 82–7

    Article  PubMed  Google Scholar 

  57. Recker RR, Kimmel DB, Hinders S, et al. Anti-fracture efficacy of calcium in elderly women. J Bone Miner Res 1994; 9: S154

    Google Scholar 

  58. NIH Consensus Development Panel on Optimal Calcium Intake. Optimal calcium intake. JAMA 1994; 272: 1942–8

    Article  Google Scholar 

  59. Eriksen EF, Colvard DS, Berg NJ, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988; 241: 84–6

    Article  PubMed  CAS  Google Scholar 

  60. Moore M, Bracker M, Sartoris D, et al. Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density. J Bone Miner Res 1990; 5: 659–64

    Article  PubMed  CAS  Google Scholar 

  61. Felson DT, Zhang Y, Hannan MT, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993; 329: 1141–6

    Article  PubMed  CAS  Google Scholar 

  62. Wasnich R, Yano K, Vogel J. Postmenopausal bone loss at multiple skeletal sites: relationship to estrogen use. J Chronic Dis 1983; 36: 781–90

    Article  PubMed  CAS  Google Scholar 

  63. Spector TD, Brennan P, Harris PA, et al. Do current regimes of hormone replacement therapy protect against subsequent fractures? Osteoporos Int 1992; 2: 219–24

    Article  PubMed  CAS  Google Scholar 

  64. Barret-Connor E. Postmenopausal estrogen and prevention bias. Ann Int Med 1994; 115: 455–6

    Google Scholar 

  65. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 1987; 106: 40–5

    PubMed  CAS  Google Scholar 

  66. Gotfredsen A, Riis BJ, Christiansen C. Total and local bone mineral during estrogen treatment: a placebo controlled trial. Bone Miner 1986; 1: 167–73

    PubMed  CAS  Google Scholar 

  67. Munk Jensen N, Pors Nielsen S, Obel EB, et al. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study. BMJ 1988; 296: 1150–2

    Article  PubMed  CAS  Google Scholar 

  68. Stevenson JC, Cust MP, Gangar KF, et al. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 1990; 336: 265–9

    Article  PubMed  CAS  Google Scholar 

  69. Lufkin EG, Wahner HW, O’Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992; 117: 1–9

    PubMed  CAS  Google Scholar 

  70. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–37

    PubMed  CAS  Google Scholar 

  71. Bergkvist L, Adami HO, Persson I, et al. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 1989; 130: 221–8

    PubMed  CAS  Google Scholar 

  72. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer — results from epidemiologic studies. Am J Obstet Gynecol 1993; 168: 1473–80

    PubMed  CAS  Google Scholar 

  73. Key TJ, Pike MC. The role of estrogens and progestogens in the epidemiology of and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29–43

    Article  PubMed  CAS  Google Scholar 

  74. Hulka BS. Hormone-replacement therapy and the risk of breast cancer. CA Cancer J Clin 1990; 40: 289–96

    Article  PubMed  CAS  Google Scholar 

  75. Ott SM, Chestnut CH. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989; 110: 267–74

    PubMed  CAS  Google Scholar 

  76. Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: a randomized controlled study. Ann Intern Med 1990; 113: 649–55

    PubMed  CAS  Google Scholar 

  77. Tilyard MW, Spears GF, Thomson J, et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992; 326: 357–62

    Article  PubMed  CAS  Google Scholar 

  78. Gallagher JC, Riggs BL. Action of 1, 25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate. Metabolism 1990; 39: 30–4

    Article  PubMed  CAS  Google Scholar 

  79. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637–42

    Article  PubMed  CAS  Google Scholar 

  80. Chapuy MC, Chapuy P, Meunier PJ. Calcium and vitamin D supplements: effects on calcium metabolism in elderly people. Am J Clin Nutr 1987; 46: 324–8

    PubMed  CAS  Google Scholar 

  81. Storm T, Thamsborg G, Steiniche T, et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322: 1265–71

    Article  PubMed  CAS  Google Scholar 

  82. Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323: 74–9

    Article  Google Scholar 

  83. Civitelli R, Gonnelli S, Zacchei F, et al. Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 1988; 82: 1268–74

    Article  PubMed  CAS  Google Scholar 

  84. Reginster JY, Albert A, Lecart MP, et al. 1-year controlled randomized trial on prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 1987; 2: 1481–6

    Article  PubMed  CAS  Google Scholar 

  85. Overgaard K, Riis BJ, Christiansen C, et al. Effect of salcatonin given intranasally on early postmenopausal bone loss. BMJ 1989; 299: 477–9

    Article  PubMed  CAS  Google Scholar 

  86. Overgaard K, Hansen MA, Jensen SB, et al. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 1992; 305: 556–61

    Article  PubMed  CAS  Google Scholar 

  87. Riggs BL, Hodgson SF, O’Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322: 802–9

    Article  PubMed  CAS  Google Scholar 

  88. Kleerekoper M, Peterson EL, Nelson DA, et al. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int 1991; 1: 155–61

    Article  PubMed  CAS  Google Scholar 

  89. Reeve J, Meunier PJ, Parsons JA, et al. Anabolic effect of human parathyroid hormone fragment on trabecula bone in involutional osteoporosis: a multicentre trial. BMJ 1980; 280: 1340–4

    Article  PubMed  CAS  Google Scholar 

  90. Finkelstein JS, Klianski A, Schaefer EH, et al. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 1994; 331: 1618–23

    Article  PubMed  CAS  Google Scholar 

  91. Brixen K, Kassem M, Eriksen EF, et al. Growth hormone (GH) and adult bone remodelling: the potential use of GH in treatment of osteoporosis. J Pediatr Endocrinol 1993; 6: 65–71

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, University Hospital, Aarhus, Tage-Hansensgade, DK-8000 Aarhus C, Denmark

    Jørgen Rungby, Anne Pernille Hermann & Leif Mosekilde

Authors
  1. Jørgen Rungby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Pernille Hermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leif Mosekilde
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rungby, J., Hermann, A.P. & Mosekilde, L. Epidemiology of Osteoporosis. Drugs & Aging 6, 470–478 (1995). https://doi.org/10.2165/00002512-199506060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199506060-00007

Keywords

Search

Navigation